CHILI – Conference on Hybrid Imaging Live

Save the date: CHILI returns on October 29, 2021!

CHILI – the Conference on Hybrid Imaging Live – will return with its engaging format on October 29, 2021. A full day of hybrid imaging awaits you with a clear focus how hybrid imaging can guide clinical therapy in a multitude of clinical applications in oncology, infection and inflammation. It will again be streamed online only and will be free of charge for everyone.

A professional studio, live moderation and live speakers will make CHILI stand out from other online conferences with pre-recorded talks from the can. CHILI is live, CHILI is fresh, CHILI is spicy.

Date: October 29, 2021

Time: 08:30-18:00 (CET)

Location: Online only

Credits: A request for 7 CME credits was made.

Registration: FREE (opens soon)

Programme

The four sessions of CHILI will cover various aspects relating to the fusion of radiology and nuclear medicine with a special focus on its clinical application and therapy management. The first three sessions are dedicated to exploring ways to guide clinical therapy with the use of hybrid imaging in the fields of oncology, infection and inflammation. Each of the lectures will be followed by a discussion and Q&A with the audience.

The conference will conclude with a session dedicated to new developments that are on the horizon for hybrid imaging, such as the great leap for full body PET/CT, how to evolve clinical applications for artificial intelligence in multimodality hybrid imaging as well as the translational potential of novel molecular imaging probes.

Please note that the programme is still subject to change.

 

08:25-10:15

Session 1

Oncology 1: Hybrid imaging as the standard of care

show details +

08:25-08:30 – Introduction to CHILI 4.0 (Clemens Cyran)

 

08:30-08:50
PET/CT in lymphoma – the standard of clinical care
tba

 

08:50-09:10
Lung carcinoma – the challenges in staging and therapy monitoring
tba

 

09:10-09:30
Why PET/CT in HNSCC?
tba

 

09:10-09:30
Melanoma: imaging-based therapeutic management
tba

 

09:50-10:15
Q&A with the experts

 

10:30-12:15

Session 2

Oncology 2: The world beyond FDG

show details +

10:30-10:50
Neuroendocrine tumors: therapeutic magagement with SSR-targeting tracers
Clemens Cyran, Munich /DE

 

10:50-11:10
Prostate carcinoma: PSMA PET/CT in clinical decision guidance
tba

 

11:10-11:30
FAPI PET: the new FDG in solid tumors?
tba

 

11:30-11:50
FET PET/MRI in neuro-oncology
tba

 

11:50-12:15
Discussion and Q&A with the experts

 

12:30-13:15

Special session

Sponsored symposium & discussion

More info will follow soon.

 

13:30-15:15

Session 3

Infection and Inflammation

show details +

13:30-13:50
Rheumatological diseases: the role of hybrid imaging
tba

 

13:50-14:10
Prothesis infection – from aortic replacements to endoprothesis
Michel Eisenblätter, Freiburg /DE

 

14:10-14:30
Specific tracers in imaging of inflammation
José Vercher-Conejero, Barcelona /ES

 

14:30-14:50
Hybrid imaging in COVID-19: What have we learned?
tba

 

14:50-15:15
Discussion and Q&A with the experts

 

15:30-16:00

Special session

Sponsored symposium & discussion

More info will follow soon.

 

16:15-18:00

Session 4

New Horizons for Hybrid Imaging

show details +

16:15-16:40
Total body PET/CT – key benefits and applications
Thomas Beyer, Vienna /AT

 

16:40-17:05
AI in multimodality hybrid imaging
tba

 

17:05-17:30
Novel molecular imaging probes for oncologic imaging and what’s their translational potential
tba

 

17:30-18:00
Round table discussion:
The prospects of clinical implementation for new modalities, probes and algorithms on the horizon.